

CTEV reported better-than-expected Q2 results and raised FY26 sales guidance. Analysts maintain Buy ratings with increased price targets.
You can purchase shares of Claritev (NYSE:CTEV) through any online brokerage.
Other companies in Claritev’s space includes: Veeva Systems Inc (NYSE:VEEV), Doximity Inc (NYSE:DOCS), Waystar Holding Corp (NASDAQ:WAY), HeartFlow Inc (NASDAQ:HTFL) and Schrodinger Inc (NASDAQ:SDGR).
Claritev has a consensus price target of $47.00.
The stock price for Claritev (NYSE: CTEV) is $22.71 last updated November 6, 2026 at 4:00 PM EST.
There are no upcoming dividends for Claritev.
Claritev does not have any upcoming earnings scheduled.
There is no upcoming split for Claritev.
Claritev is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that...